BETHLEHEM, Pa., Sept. 15, 2025 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Tromethamine Injection in the EXCEL® IV Container 500 mL in the U.S. market. This addition enhances the company’s ability to serve the diverse needs of providers and their patients.
A team of University of Saskatchewan (USask) researchers have identified a pathway to help the human body defend itself against sepsis—a life-threatening condition caused by the body’s inappropriate response to an infection.
In a new study, University of California, Irvine chemical and biomolecular engineering researchers report the creation of biomolecules that can help grow light-sensitive heart muscle cells in the laboratory. The development enables a biotechnology that could deliver light-triggered signals to the heart, improving its function, without requiring genetic modifications or invasive procedures.
MIT CSAIL researchers developed a tool that can model the shape and movements of fetuses in 3D, potentially assisting doctors in finding abnormalities and making diagnoses.
Expanded indication provides patients with knee osteoarthritis with the benefits of Embosphere’s consistent, predictable, and effective clinical results
Novocure (Nasdaq:NVCR) announced today that it received regulatory approval in Japan for its Optune Lua wearable device.
Johnson & Johnson MedTech‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe.
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ — Shenzhen Sunsred Technology Co., Ltd. is shaking things up in the wellness tech world with its latest lineup of red light therapy devices.